Kemwell Biopharma was proud to attend and exhibit at BioProcess International Conference 2012 in Providence Rhode Island, Oct 8-12. The world’s largest gathering of industry suppliers & collaborators, BPI is the premier annual bioprocessing event for the development of biologics – covering critical Regulatory, CMC topics, from cell culture, purification, formulation, analytical, through scale-up and production.
This years meeting agenda included 180+ speakers presenting new and unpublished data to help pharmaceutical & biotech companies navigate the biologics landscape and plan accordingly.
Examples of syposia:
- Enhancing Manufacturing & Development
- Product Lifecycle Management
- Cell Culture & Upstream Processing
- Developing Truly Continuous Drug Substance Processes
- Recovery & Purification
- ADC Development & Production
- Viral Clearance for Biologics
- Analytical Technologies
- Drug Product Development
- Formulation Strategies for Protein Therapeutics
- Delivery Strategies for Biologics
- Vaccine Development & Production
Kemwell Biopharma is contract provider of CMC services to the pharmaceutical industry. With manufacturing locations in Bangalore India, and Uppsala Sweden, Kemwell offers services ranging from Clinical (CTM) Manufacturing, Commercial Manufacturing, Formulation Development, Analytical Development, & Packaging/Storage/Distribution.
With the global market for biosimilars forecast to exceed $4 billion by 2015, there is a great deal of focus on the development and commercialization of biopharmaceuticals, particularly bringing cost-effective biologic theapeutics to patients.
Kemwell Biopharma is gearing up to meet the demand at our NEW BioPharmaceutical manufacture facility in Bangalore India. In Q3 of 2012, Kemwell will offer full service contract biopharmaceutical process development, manufacturing, formulation, and fill-finish capabilities at our newest 15,000 m2 (135,000 sq ft) Bangalore, India facility.